SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Le coin des francophones -- Ignore unavailable to you. Want to Upgrade?


To: richhhh who wrote (19232)6/6/2000 11:17:00 AM
From: faro  Read Replies (2) | Respond to of 77509
 
C'est bien mon id‚e aussi.

Je tiens le mˆme piton que toi.

Faro



To: richhhh who wrote (19232)6/6/2000 11:18:00 AM
From: pallmer  Respond to of 77509
 
Richhhh,

Pour info :

Pallmer

Sequenom, Inc.

N MARKET GUIDE INC
G
K Copyright (c) 2000, Market Guide Inc., All rights reserved
G TABLE OF CONTENTS
L
OUS;SQNM[MG]/2 L<<< Company Description
OUS;SQNM[MG]/3 L<<< Quarterly Summary
OUS;SQNM[MG]/4 L<<< Company To Industry Ratio Comparison
OUS;SQNM[MG]/5 L<<< Share Ownership & Price Performance
OUS;SQNM[MG]/6 L<<< Capitalization, Officers & Address
OUS;SQNM[MG]/7 L<<< Annual Income Statements
OUS;SQNM[MG]/8 L<<< Annual Income Statements - Continued
OUS;SQNM[MG]/9 L<<< Quarterly & Year To Date Income Statements
OUS;SQNM[MG]/10 L<<< Annual & Quarterly Balance Sheets
OUS;SQNM[MG]/11 L<<< Annual & Year To Date Statement of Cash Flows
G
G
G
OComplete Financials: G March 2000 OExchange G NASD
O G OFY END G DEC
L ISSUE DATA (06/02/00) PER SHARE DATA RATIOS
OPrice $ G 26.50 OEPS (TTM) $ G -32.54 OP/E (TTM) G NM
O52W High $ G 191.25 ODiv. Rate $ G 0.00 OYield G 0.00 %
O52W Low $ G 17.00 OBook Value $ G 6.64 OPrice/Book G 3.99
OShrs Out G 24.27 Mil OCash $ G 6.59 OROE (TTM) G -48.70 %
OFloat G 5.30 Mil ORev (TTM) $ G 0.28 OROA (TTM) G -42.17 %
OMon. Vol G 11.71 Mil O G OCurr. Ratio G 26.12
OBeta G NA O G OLT Dbt/Eqty G 0.01
O BRIEF: G Sequenom, Inc. is primarily involved in the research
G and development of high definition DNA analysis tools for
G industrial biomedical and life science applications, used
G for improving health, agriculture and livestock. For the 3
G months ended 3/31/00, revenues totaled $1.6M, up from $0.
G Net loss totaled $14.3M, up from $3.4M. Results reflect
G initial sales of MassARRAY systems and disposable kits,
G offset by increased development and personnel expenses.
G

G L HISTORICAL QUARTERLY RESULTS ($000)
LREVENUE 1998 1999 2000
O1st Qtr MAR G 0 0 1,575
O2nd Qtr JUN G 0 0
O3rd Qtr SEP G 126 81
O4th Qtr DEC G 225 98
LEPS (U.S. Dollars per share)
O1st Qtr MAR G 0.000 -10.271 -0.850
O2nd Qtr JUN G 0.000 0.000
O3rd Qtr SEP G -20.120 -26.650
O4th Qtr DEC G -13.430 -5.030
G
G 9/98 Summ. Q = 9 month numbers. 9/99 Summ. Q = 6 month
G numbers.
G
L DIVIDENDS EMPLOYEES
O Last Dividend Decl. G $ NA O # Employees G 116
O Last Div Ex-Date G NA O Sales/Employee (TTM) G 15,121
O Last Div Pay Date G NA O Net. Income/Empl.(TTM G) NM
G
LCOMPANY COMPARISON TO THE BIOTECHNOLOGY AND S&P 500 AGGREGATES
LVALUATION RATIOS: COMPANY INDUSTRY S&P 500
OP/E Ratio G NM 55.07 36.58
ODividend Yield G 0.00 0.02 1.11
OPrice to Tangible Book G 3.99 14.94 12.63
OPrice to Book G 3.99 13.85 9.00
OPrice to Free Cash Flow G -8.30 71.04 45.64
LGROWTH STATISTICS:
O3 Yr Rev Growth G -41.48 29.47 16.31
O3 Yr EPS Growth G NM 26.73 18.08
O3 Yr Div Growth G NM -4.17 11.77
OReinvestment Rate G 100.00 99.98 75.13
LPROFITABILITY RATIOS:
ONet Profit Margin G NM 19.77 12.16
OReturn on Equity G -48.70 8.65 22.10
OInterest Coverage G -6.01 5.89 9.89
LFINANCIAL STRENGTH RATIOS:
OCurrent Ratio G 26.12 7.62 1.65
OLT Debt to Equity G 0.01 0.26 0.77
OTotal Debt to Equity G 0.01 0.29 0.95
L INSTITUTIONAL OWNERSHIP INSIDER TRADING (Prev. 6 months)
G O % Shares Out. Owned G 13.90 % ONet Insider Trades G 9
O # of Institutions G 68 O# Buy Transactions G 9
O Total Shs Held G 3.373 Mil O# Sell Transactions G 0
O 3 Mo. Net Purch. G 3.373 Mil ONet Shares Bought G 0.097 Mil
O 3 Mo. Shs Purch. G 3.373 Mil O# Shares Bought G 0.097 Mil
O 3 Mo. Shs Sold G 0.000 Mil O# Shares Sold G 0.000 Mil
G
O 4 Week Price % Change G -8.2% O 4 Week Rel. Price % Change G -10.7%
O 13 Week Price % Change G -78.2% O 13 Week Rel. Price % Change G -79.2%
O 26 Week Price % Change G NA% O 26 Week Rel. Price % Change G NA%
O 52 Week Price % Change G NA% O 52 Week Rel. Price % Change G NA%
OYTD Week Price % Change G NA% OYTD Week Rel. Price % Change G NA%
G
L SHORT INTEREST
O Current month G 0.112 Mil
O Previous month G 0.144 Mil
O Avg Daily Vol. G 0.849 Mil
G
LMARKET MAKERS: G NITE INCA ISLD REDI MASH SHWD RSSF
OEQUITY: GCommon Stock $.001 Par, 4/00, 75M auth., 24,273,566 issd.
GInsiders control approx. 30%. Alpinvest International B.V.
Gowns 7%. Initial Public Offering 2/1/00, 5,250,000 shares
G@ $26 by Warburg Dillon Read LLC. *All Preferred stock
Gconverted into Common upon completion of IPO.
G
G
OOFFICERS: G Helmut Schuhsler Ph.D., Chmn., Hubert Koster,
GVice Chmn., Toni Schuh, Pres./CEO, Stephen L. Zaniboni, Sr.
GVP/CFO, Delbert F. Foit Jr., COO. TRANSFER AGENT:
GAmerican Stock Transfer and Trust. Company incorporated
G1994 in DE. Inquiries to: Director of Investor Relations.
O ADDRESS & PHONE NUMBERS
GSequenom, Inc.
G11555 Sorrento Valley Road
GSan Diego, CA 92121
GPHONE: (858) 350-0345
G FAX: (858) 350-3044
G
G
LANNUAL INCOME STATEMENT ($000)
L 12M 12/31/96 12M 12/31/97 12M 12/31/98 12M 12/31/99
OR&D Grants G 893 527 351 179
O Total Revenue G 893 527 351 179
OResearch/Development G 3,136 3,532 6,188 10,291
OGeneral/Admin. G 1,032 1,861 4,218 8,239
OAmort. Dfrd. Comp. G 0 0 0 4,376
O Total Expenses G 4,168 5,393 10,406 22,906
O Operating Income G -3,275 -4,866 -10,055 -22,727











LANNUAL INCOME STATEMENT ($000) (Contd.)
L 12M 12/31/96 12M 12/31/97 12M 12/31/98 12M 12/31/99
O Operating Income G -3,275 -4,866 -10,055 -22,727
OInterest Expense G -275 -308 -613 -790
OOther, Net G 73 57 397 1,747
O Income Before Taxes G -3,477 -5,117 -10,271 -21,770
OIncome Taxes G 0 0 0 0
O Income After Taxes G -3,477 -5,117 -10,271 -21,770
O Pri/Bas EPS Ex. XOrd G -23.454 -22.617 -33.334 -26.232
O Pri/Bas EPS In. XOrd G -23.454 -22.617 -33.334 -26.232
OPrimary/Basic Avg Sh G 148.25 226.25 308.12 829.90
OCommon Dividends/Shr G 0.0000 0.0000 0.0000 0.0000








LSELECTED INCOME STATEMENT ITEMS ($000)
L QUARTERS YEAR TO DATE
L 3M 03/31/99 3M 03/31/00 3M 03/31/99 3M 03/31/00
ORevenue G 0 1,575 0 1,575
OOperating Expenses G 3,455 12,975 3,455 12,975
O Operating Income G -3,455 -11,400 -3,455 -11,400
ONon-Operating Income G 218 1,555 218 1,555
ONon-Operating Expenses G -170 -4,480 -170 -4,480
O Income Before Taxes G -3,407 -14,325 -3,407 -14,325
OIncome Taxes G 0 0 0 0
OAdjustments to Income G 0 0 0 0
O Inc. for Primary EPS G -3,407 -14,325 -3,407 -14,325
O Pri/Bas EPS Ex. XOrd G -10.275 -0.853 -10.275 -0.853
ODisc Opns + Xord Items G 0 0 0 0
O Pri/Bas EPS In. XOrd G -10.275 -0.853 -10.275 -0.853
OPrimary/Basic Avg Sh G 331.57 16,803.89 331.57 16,803.89
O Dilutd EPS Excl XOrd G -10.275 -0.853 -10.275 -0.853
O Dilutd EPS Incl XOrd G -10.275 -0.853 -10.275 -0.853
OCommon Dividends/Shr G 0.000 0.000 0.000 0.000

LSELECTED BALANCE SHEET ITEMS ($000)
L YEAR ENDING QUARTER ENDING
L 12/31/98 12/31/99 03/31/00
OCash & ST Investments G 28,498 21,617 159,736
OReceivables G 0 105 1,079
O Total Current Assets G 28,750 23,407 161,941
OLT Investments G 0 0 0
OFixed Assets G 3,942 6,294 6,168
O Total Assets G 32,778 29,754 168,157
OAccounts Payable G 2,385 4,426 5,720
OST Debt & Curr LTD G 349 462 479
O Total Current Liab. G 2,734 4,888 6,199
OLT Debt & Cap Leases G 6,694 6,323 1,064
O Total Liabilities G 10,142 12,214 7,263
OPreferred Stock G 13 15 0
OCommon/Paid In Capital G 46,799 66,302 221,243
ORetained Earnings G -21,734 -43,505 -57,829
O Total Equity G 22,635 17,538 160,894
OShares Outstanding G 331 2,299 24,243

LSELECTED STMT OF CASH FLOWS - INDIRECT METHOD ($000)
L ANNUAL YEAR TO DATE
L 12M 12/31/98 12M 12/31/99 3M 03/31/99 3M 03/31/00
ONet Income G -10,271 -21,770 -3,406 -14,325
ODepreciation & Amort. G 961 6,318 0 0
ONon Cash Items G 10 103 396 9,343
O Total Operating CF G -7,795 -14,710 -2,857 -3,852
OCapital Expenditures G -3,831 -4,478 -955 -474
O Total Investing CF G -23,746 -1,063 -9,572 -4,675
ODividends Paid G 0 0 0 0
OSale (Purch.) of Stock G 35,806 11,999 11,874 145,818
ONet Borrowings G 3,356 572 525 -3,199
O Total Financing CF G 39,162 12,571 12,399 142,619
OExchange Rate Effect G 104 -156 -110 -135
ONet Change In Cash G 7,727 -3,359 -141 133,957
OOper CF-Cap Exp-Div Pd G -11,626 -19,188 -3,812 -4,326



KCopyright (c) 2000, Market Guide Inc., All rights reserved
G

Jun-03-2000 18:05 GMT
Symbols:
US;SQNM
Source B Market Guide